Abstract:SignificanceGlioblastoma (GBM) is a rare but deadly form of brain tumor with a low median survival rate of 14.6 months, due to its resistance to treatment. An independent simulation of the INtraoperative photoDYnamic therapy for GliOblastoma (INDYGO) trial, a clinical trial aiming to treat the GBM resection cavity with photodynamic therapy (PDT) via a laser coupled balloon device, is demonstrated.AimTo develop a framework providing increased understanding for the PDT treatment, its parameters, and their impact on the clinical outcome.ApproachWe use Monte Carlo radiative transport techniques within a computational brain model containing a GBM to simulate light path and PDT effects. Treatment parameters (laser power, photosensitizer concentration, and irradiation time) are considered, as well as PDT's impact on brain tissue temperature.ResultsThe simulation suggests that 39% of post-resection GBM cells are killed at the end of treatment when using the standard INDYGO trial protocol (light fluence = 200 J/cm2 at balloon wall) and assuming an initial photosensitizer concentration of 5 μM. Increases in treatment time and light power (light fluence = 400 J/cm2 at balloon wall) result in further cell kill but increase brain cell temperature, which potentially affects treatment safety. Increasing the p hotosensitizer concentration produces the most significant increase in cell kill, with 61% of GBM cells killed when doubling concentration to 10 μM and keeping the treatment time and power the same. According to these simulations, the standard trial protocol is reasonably well optimized with improvements in cell kill difficult to achieve without potentially dangerous increases in temperature. To improve treatment outcome, focus should be placed on improving the photosensitizer.ConclusionsWith further development and optimization, the simulation could have potential clinical benefit and be used to help plan and optimize intraoperative PDT treatment for GBM.

Current Photodynamic Therapy for Glioma Treatment: An Update

Photosensitizers for Photodynamic Therapy of Brain Cancers—A Review

Molecular Determinants for Photodynamic Therapy Resistance and Improved Photosensitizer Delivery in Glioma

Using Light for Therapy of Glioblastoma Multiforme (GBM)

Advances in two-photon absorption photodynamic therapy of glioma based on porphyrin-based metal-organicframework composites

Photodynamic Therapy and Immunological View in Gastrointestinal Tumors

Simulating photodynamic therapy for the treatment of glioblastoma using Monte Carlo radiative transport

Immunomodulatory Effects by Photodynamic Treatment of Glioblastoma Cells In Vitro

Photodynamic and sonodynamic therapy synergy: mechanistic insights and cellular responses against glioblastoma multiforme

Glioblastoma Multiforme: The Latest Diagnostics and Treatment Techniques

A Comprehensive Overview of Modern Therapeutic Approaches

Photodynamic Therapy In Adult Intra-Axial Brain Tumours

Fiber Optic‐Mediated Type I Photodynamic Therapy of Brain Glioblastoma Based on an Aggregation‐Induced Emission Photosensitizer

Achievements and prospects for further development of photodynamic therapy technology in the treatment of cerebral tumors

NDs@PDA@ICG Conjugates for Photothermal Therapy of Glioblastoma Multiforme

Feasibility of Photodynamic Therapy for Glioblastoma with the Mitochondria-Targeted Photosensitizer Tetramethylrhodamine Methyl Ester (TMRM)

Photodynamic Therapy for Eye, Ear, Laryngeal Area, and Nasal and Oral Cavity Diseases: A Review

Glioblastoma Therapy: Past, Present and Future

Photodynamic therapy in neurooncology

Pharmacological strategies for improving the prognosis of glioblastoma

The Current Status of Photodynamic Therapy in Cancer Treatment